Did she really say that estrogen doesn't cause breast cancer?
Yes. I did. And I stand by it.
I know that might feel shocking — maybe even alarming — given what most of us have been told for the past two decades. But the science tells a different story than the headlines did in 2002, and it's time we talked about it. Buckle up, because this gets technical.
First, Let's Go Back to 2002
The belief that estrogen in menopausal hormone therapy causes breast cancer traces back to a single moment: the halting of the Women's Health Initiative (WHI) study in 2002. The study was stopped because researchers reported an increased risk of breast cancer in women taking hormone replacement therapy. The headlines that followed changed the way an entire generation of women and physicians thought about hormones.
But here's the thing: they didn't quite get it right. And it is taking years to untangle what actually happened.
Two Hormones, Two Very Different Stories
Before we dive into the data, we need to establish some basics:
The two hormones at play in this conversation are estrogen and progesterone. Your body makes both naturally. Progesterone is produced after ovulation and helps regulate the shedding of the uterine lining. It also serves a critical protective function: it offsets the effects of estrogen on the uterus. When progesterone is too low to counterbalance estrogen, the risk of uterine cancer increases.
This is why, when prescribing menopausal hormone therapy (MHT) to a woman who still has her uterus, we always include both estrogen and a form of progesterone. Women who have had a hysterectomy don't need to take a form of progesterone.
The WHI had three groups:
- Women on no hormone therapy
- Women taking both estrogen and progesterone (who still had a uterus)
- Women who had a hysterectomy taking estrogen only
Here's a critical detail that got lost in the 2002 headlines: the hormones used in this study were not what we use today. The estrogen was conjugated equine estrogen (CEE), and the progesterone component was a synthetic progestin called medroxyprogesterone acetate — commonly known as Provera (MPA). These days, we typically use estradiol and micronized progesterone, which are much more structurally similar to what your body naturally produces. The WHI was not studying the hormones we use today.
What the Data Actually Showed — Including the Follow-Up
The researchers continued to follow the women from the WHI even after the study was halted. And the results were striking.
Women who took both CEE and MPA had an increased risk of breast cancer — that part was true. But women who took CEE only (the estrogen-alone arm) showed a slight decrease in their breast cancer risk.
A study published in 2024 analyzed prescriptions for 10 million women on Medicare, all over age 65 and found that those who had a hysterectomy and took estrogen only had a 19% overall reduction in mortality and a 16% reduction in breast cancer–specific death, though this varied by type of estrogen and route of administration.
The Real Risk Breakdown
- Estrogen + synthetic progestin (MPA): 19% increased risk of breast cancer
- Synthetic progestin only: 21% increased risk
- Estrogen + micronized progesterone (bio-similar): 10% increased risk
- Micronized progesterone only: 10% decreased risk
- Estrogen alone: no increase to slight reduction in breast cancer risk
So What Does the Risk Actually Look Like in Real Numbers?
It's now been 24 years since the WHI headlines shook the medical world. And we have a lot more data to work with.
Even the increased risk associated with MPA, the synthetic progestin most implicated in breast cancer risk, works out to a 0.09% absolute increase, or roughly 9 additional breast cancer cases per 10,000 women per year. That's not zero, and it's worth knowing. But it's also a very different number than what most women imagine when they hear that hormone therapy "causes" breast cancer.
As for estrogen? The data shows no increase, and possibly a slight reduction, in breast cancer risk. And what limited data we have on micronized progesterone (the body-similar form we commonly use today) also shows no increase in breast cancer risk.
The Bottom Line
The fear around estrogen and breast cancer was born from a misread of incomplete data — data that used older, synthetic forms of hormones that don't reflect what we prescribe today. What we actually know is this:
- Estrogen does not appear to cause breast cancer.
- The breast cancer risk signal in the WHI was driven primarily by the synthetic progestin MPA — not estrogen.
- The hormones we use today — estradiol and micronized progesterone — have a much more favorable safety profile than what was studied in 2002.
- Fear-based decisions made in the absence of nuanced data have left millions of women undertreated and suffering.
So yes. I said it. Estrogen doesn't cause breast cancer. And I'll keep saying it.